These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8038598)

  • 1. Isolated limb perfusion: past experience and present studies using a minimal-access approach.
    Rosin DR
    Melanoma Res; 1994 Mar; 4 Suppl 1():51-5. PubMed ID: 8038598
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolated limb perfusion for melanoma.
    Kroon BB; Noorda EM; Vrouenraets BC; van Slooten GW; Nieweg OE
    Surg Oncol Clin N Am; 2008 Oct; 17(4):785-94, viii-ix. PubMed ID: 18722918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation limb perfusion for melanoma: current trends and future directions.
    Coit DG
    Melanoma Res; 1994 Mar; 4 Suppl 1():57-60. PubMed ID: 8038599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of isolated limb perfusion to manage recurrent malignant melanoma.
    Ma D; Ariyan S
    Clin Plast Surg; 2000 Jul; 27(3):441-50, ix. PubMed ID: 10941564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there any reason to delay introduction of tumor necrosis factor in the management of in-transit metastasis of unresectable melanoma?
    Garrido-Laguna I; Ponz M; Espinós J
    J Clin Oncol; 2007 Mar; 25(9):1149; author reply 1149-51. PubMed ID: 17369585
    [No Abstract]   [Full Text] [Related]  

  • 6. [Isolated hyperthermic perfusion of the extremities with cytostatic agents. A method of treatment in malignant melanoma and soft tissue sarcoma].
    Kettelhack C; Schlag P
    Dtsch Krankenpflegez; 1989 Sep; 42(9):597-601. PubMed ID: 2518209
    [No Abstract]   [Full Text] [Related]  

  • 7. Toxicities associated with hyperthermic isolated limb perfusion and isolated limb infusion in the treatment of melanoma and sarcoma.
    Möller MG; Lewis JM; Dessureault S; Zager JS
    Int J Hyperthermia; 2008 May; 24(3):275-89. PubMed ID: 18393005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated limb perfusion and isolated limb infusion for malignant lesions of the extremities.
    Sanki A; Kroon HM; Kam PC; Thompson JF
    Curr Probl Surg; 2011 Jun; 48(6):371-430. PubMed ID: 21549235
    [No Abstract]   [Full Text] [Related]  

  • 9. [Perfusion of the extremities in malignant melanoma. Indication, technic and results].
    Nagel K; Junginger T
    Dtsch Med Wochenschr; 1987 Oct; 112(42):1626-9. PubMed ID: 3665750
    [No Abstract]   [Full Text] [Related]  

  • 10. Regional isolation perfusion in melanoma of the limbs; accomplishments, unsolved problems, future.
    Kroon BB
    Eur J Surg Oncol; 1988 Apr; 14(2):101-10. PubMed ID: 3360151
    [No Abstract]   [Full Text] [Related]  

  • 11. Current status of hyperthermic limb perfusion for in-transit melanoma.
    Ross MI
    Int J Hyperthermia; 2008 May; 24(3):205-17. PubMed ID: 18392999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliation of skeletal melanoma metastases with isolated limb perfusion chemotherapy.
    Rajpar SF; Martin-Clavijo A; Marsden JR; Byrne D
    Dermatol Surg; 2006 Sep; 32(9):1199-201. PubMed ID: 16970706
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolated limb perfusion for unresectable melanoma of the extremities.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Kroon BB
    Arch Surg; 2004 Nov; 139(11):1237-42. PubMed ID: 15545572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperthermic isolated limb perfusion with tumor necrosis factor is a useful therapy for advanced melanoma of the limbs.
    Lejeune FJ; Eggermont AM
    J Clin Oncol; 2007 Apr; 25(11):1449-50; author reply 1450-1. PubMed ID: 17416870
    [No Abstract]   [Full Text] [Related]  

  • 15. Isolated limb infusion: a review.
    Kroon HM; Thompson JF
    J Surg Oncol; 2009 Aug; 100(2):169-77. PubMed ID: 19365813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isolated infusion effective in melanoma and sarcoma. Good alternative for regional isolated cytostatic perfusion].
    Kroon HM; Thompson JF; Hoekstra HJ
    Ned Tijdschr Geneeskd; 2009 Mar; 153(11):508-14. PubMed ID: 19402327
    [No Abstract]   [Full Text] [Related]  

  • 17. Future directions in regional treatment strategies for melanoma and sarcoma.
    Beasley GM; Ross MI; Tyler DS
    Int J Hyperthermia; 2008 May; 24(3):301-9. PubMed ID: 18393007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation-perfusion: a valuable alternative in managing locally recurrent and in-transit melanoma.
    Norvell ST; Bodurtha AJ
    Can J Surg; 1983 Jan; 26(1):8. PubMed ID: 6821770
    [No Abstract]   [Full Text] [Related]  

  • 19. Loco-regional perfusions (stop-flow techniques): state of art and future.
    Guadagni S
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):119-22. PubMed ID: 16767917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regional isolated perfusion: also applicable in elderly patients].
    Noorda EM; Vrouenraets BC; Nieweg OE; Kroon BB
    Ned Tijdschr Geneeskd; 2003 Mar; 147(12):529-33. PubMed ID: 12693077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.